Awaiting product image

Bcr – Abl Quantitative

₹7,000.00

15 minutes
Categories: , Tags: , , , , , , , , ,

The BCR-ABL Quantitative Test is a molecular diagnostic test that measures the amount (level) of the BCR-ABL fusion gene transcript in the blood or bone marrow using quantitative polymerase chain reaction (qPCR). Unlike qualitative tests that only detect presence or absence, this test provides a numerical value that reflects the burden of leukemic cells producing the BCR-ABL fusion protein.
This test is essential for monitoring patients with:
• Chronic Myeloid Leukemia (CML)
• Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)
It helps track treatment response, especially to tyrosine kinase inhibitors (TKIs), and detect minimal residual disease (MRD) or relapse.

Description

Why It’s Done:

This test is done to:
• Monitor disease progression or remission in patients receiving treatment for CML or Ph+ ALL
• Assess treatment effectiveness, particularly with TKIs like imatinib, dasatinib, or nilotinib
• Detect minimal residual disease that may indicate relapse
• Guide treatment adjustments based on the level of BCR-ABL transcripts

Preparation:

• No special preparation such as fasting is required.
• A blood sample is collected, typically from a vein.
• Inform your healthcare provider about recent treatments or medications.
• Regular testing intervals may be recommended to closely monitor disease status.

Related products